Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Non-cash Items (2024 - 2025)

Historic Non-cash Items for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to $1.1 million.

  • Prelude Therapeutics' Non-cash Items fell 8650.06% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 8650.06%. This contributed to the annual value of $100000.0 for FY2024, which is N/A changed from last year.
  • Per Prelude Therapeutics' latest filing, its Non-cash Items stood at $1.1 million for Q3 2025, which was down 8650.06% from $9.5 million recorded in Q2 2025.
  • Prelude Therapeutics' 5-year Non-cash Items high stood at $9.5 million for Q2 2025, and its period low was $100000.0 during Q4 2024.